Cargando…
Cissus quadrangularis (Hadjod) Inhibits RANKL-Induced Osteoclastogenesis and Augments Bone Health in an Estrogen-Deficient Preclinical Model of Osteoporosis Via Modulating the Host Osteoimmune System
Osteoporosis is a systemic skeletal disease characterised by low bone mineral density (BMD), degeneration of bone micro-architecture, and impaired bone strength. Cissus quadrangularis (CQ), popularly known as Hadjod (bone setter) in Hindi, is a traditional medicinal herb exhibiting osteoprotective p...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857034/ https://www.ncbi.nlm.nih.gov/pubmed/36672152 http://dx.doi.org/10.3390/cells12020216 |
_version_ | 1784873774719434752 |
---|---|
author | Azam, Zaffar Sapra, Leena Baghel, Kalpana Sinha, Niharika Gupta, Rajesh K. Soni, Vandana Saini, Chaman Mishra, Pradyumna K. Srivastava, Rupesh K. |
author_facet | Azam, Zaffar Sapra, Leena Baghel, Kalpana Sinha, Niharika Gupta, Rajesh K. Soni, Vandana Saini, Chaman Mishra, Pradyumna K. Srivastava, Rupesh K. |
author_sort | Azam, Zaffar |
collection | PubMed |
description | Osteoporosis is a systemic skeletal disease characterised by low bone mineral density (BMD), degeneration of bone micro-architecture, and impaired bone strength. Cissus quadrangularis (CQ), popularly known as Hadjod (bone setter) in Hindi, is a traditional medicinal herb exhibiting osteoprotective potential in various bone diseases, especially osteoporosis and fractures. However, the cellular mechanisms underpinning its direct effect on bone health through altering the host immune system have never been elucidated. In the present study, we interrogated the osteoprotective and immunoporotic (the osteoprotective potential of CQ via modulating the host immune system) potential of CQ in preventing inflammatory bone loss under oestrogen-deficient conditions. The current study outlines the CQ’s osteoprotective potential under both ex vivo and in vivo (ovariectomized) conditions. Our ex vivo data demonstrated that, in a dose-dependent manner CQ, suppresses the RANKL-induced osteoclastogenesis (p < 0.001) as well as inhibiting the osteoclast functional activity (p < 0.001) in mouse bone marrow cells (BMCs). Our in vivo µ-CT and flow cytometry data further showed that CQ administration improves bone health and preserves bone micro-architecture by markedly raising the proportion of anti-osteoclastogenic immune cells, such as Th1 (p < 0.05), Th2 (p < 0.05), Tregs (p < 0.05), and Bregs (p < 0.01), while concurrently lowering the osteoclastogenic Th17 cells in bone marrow, mesenteric lymph nodes, Peyer’s patches, and spleen in comparison to the control group. Serum cytokine analysis further supported the osteoprotective and immunoporotic potential of CQ, showing a significant increase in the levels of anti-osteoclastogenic cytokines (p < 0.05) (IFN-γ, IL-4, and IL-10) and a concurrent decrease in the levels of osteoclastogenic cytokines (p < 0.05) (TNF-α, IL-6, and IL-17). In conclusion, our data for the first time delineates the novel cellular and immunological mechanism of the osteoprotective potential of CQ under postmenopausal osteoporotic conditions. |
format | Online Article Text |
id | pubmed-9857034 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98570342023-01-21 Cissus quadrangularis (Hadjod) Inhibits RANKL-Induced Osteoclastogenesis and Augments Bone Health in an Estrogen-Deficient Preclinical Model of Osteoporosis Via Modulating the Host Osteoimmune System Azam, Zaffar Sapra, Leena Baghel, Kalpana Sinha, Niharika Gupta, Rajesh K. Soni, Vandana Saini, Chaman Mishra, Pradyumna K. Srivastava, Rupesh K. Cells Article Osteoporosis is a systemic skeletal disease characterised by low bone mineral density (BMD), degeneration of bone micro-architecture, and impaired bone strength. Cissus quadrangularis (CQ), popularly known as Hadjod (bone setter) in Hindi, is a traditional medicinal herb exhibiting osteoprotective potential in various bone diseases, especially osteoporosis and fractures. However, the cellular mechanisms underpinning its direct effect on bone health through altering the host immune system have never been elucidated. In the present study, we interrogated the osteoprotective and immunoporotic (the osteoprotective potential of CQ via modulating the host immune system) potential of CQ in preventing inflammatory bone loss under oestrogen-deficient conditions. The current study outlines the CQ’s osteoprotective potential under both ex vivo and in vivo (ovariectomized) conditions. Our ex vivo data demonstrated that, in a dose-dependent manner CQ, suppresses the RANKL-induced osteoclastogenesis (p < 0.001) as well as inhibiting the osteoclast functional activity (p < 0.001) in mouse bone marrow cells (BMCs). Our in vivo µ-CT and flow cytometry data further showed that CQ administration improves bone health and preserves bone micro-architecture by markedly raising the proportion of anti-osteoclastogenic immune cells, such as Th1 (p < 0.05), Th2 (p < 0.05), Tregs (p < 0.05), and Bregs (p < 0.01), while concurrently lowering the osteoclastogenic Th17 cells in bone marrow, mesenteric lymph nodes, Peyer’s patches, and spleen in comparison to the control group. Serum cytokine analysis further supported the osteoprotective and immunoporotic potential of CQ, showing a significant increase in the levels of anti-osteoclastogenic cytokines (p < 0.05) (IFN-γ, IL-4, and IL-10) and a concurrent decrease in the levels of osteoclastogenic cytokines (p < 0.05) (TNF-α, IL-6, and IL-17). In conclusion, our data for the first time delineates the novel cellular and immunological mechanism of the osteoprotective potential of CQ under postmenopausal osteoporotic conditions. MDPI 2023-01-04 /pmc/articles/PMC9857034/ /pubmed/36672152 http://dx.doi.org/10.3390/cells12020216 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Azam, Zaffar Sapra, Leena Baghel, Kalpana Sinha, Niharika Gupta, Rajesh K. Soni, Vandana Saini, Chaman Mishra, Pradyumna K. Srivastava, Rupesh K. Cissus quadrangularis (Hadjod) Inhibits RANKL-Induced Osteoclastogenesis and Augments Bone Health in an Estrogen-Deficient Preclinical Model of Osteoporosis Via Modulating the Host Osteoimmune System |
title | Cissus quadrangularis (Hadjod) Inhibits RANKL-Induced Osteoclastogenesis and Augments Bone Health in an Estrogen-Deficient Preclinical Model of Osteoporosis Via Modulating the Host Osteoimmune System |
title_full | Cissus quadrangularis (Hadjod) Inhibits RANKL-Induced Osteoclastogenesis and Augments Bone Health in an Estrogen-Deficient Preclinical Model of Osteoporosis Via Modulating the Host Osteoimmune System |
title_fullStr | Cissus quadrangularis (Hadjod) Inhibits RANKL-Induced Osteoclastogenesis and Augments Bone Health in an Estrogen-Deficient Preclinical Model of Osteoporosis Via Modulating the Host Osteoimmune System |
title_full_unstemmed | Cissus quadrangularis (Hadjod) Inhibits RANKL-Induced Osteoclastogenesis and Augments Bone Health in an Estrogen-Deficient Preclinical Model of Osteoporosis Via Modulating the Host Osteoimmune System |
title_short | Cissus quadrangularis (Hadjod) Inhibits RANKL-Induced Osteoclastogenesis and Augments Bone Health in an Estrogen-Deficient Preclinical Model of Osteoporosis Via Modulating the Host Osteoimmune System |
title_sort | cissus quadrangularis (hadjod) inhibits rankl-induced osteoclastogenesis and augments bone health in an estrogen-deficient preclinical model of osteoporosis via modulating the host osteoimmune system |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857034/ https://www.ncbi.nlm.nih.gov/pubmed/36672152 http://dx.doi.org/10.3390/cells12020216 |
work_keys_str_mv | AT azamzaffar cissusquadrangularishadjodinhibitsranklinducedosteoclastogenesisandaugmentsbonehealthinanestrogendeficientpreclinicalmodelofosteoporosisviamodulatingthehostosteoimmunesystem AT sapraleena cissusquadrangularishadjodinhibitsranklinducedosteoclastogenesisandaugmentsbonehealthinanestrogendeficientpreclinicalmodelofosteoporosisviamodulatingthehostosteoimmunesystem AT baghelkalpana cissusquadrangularishadjodinhibitsranklinducedosteoclastogenesisandaugmentsbonehealthinanestrogendeficientpreclinicalmodelofosteoporosisviamodulatingthehostosteoimmunesystem AT sinhaniharika cissusquadrangularishadjodinhibitsranklinducedosteoclastogenesisandaugmentsbonehealthinanestrogendeficientpreclinicalmodelofosteoporosisviamodulatingthehostosteoimmunesystem AT guptarajeshk cissusquadrangularishadjodinhibitsranklinducedosteoclastogenesisandaugmentsbonehealthinanestrogendeficientpreclinicalmodelofosteoporosisviamodulatingthehostosteoimmunesystem AT sonivandana cissusquadrangularishadjodinhibitsranklinducedosteoclastogenesisandaugmentsbonehealthinanestrogendeficientpreclinicalmodelofosteoporosisviamodulatingthehostosteoimmunesystem AT sainichaman cissusquadrangularishadjodinhibitsranklinducedosteoclastogenesisandaugmentsbonehealthinanestrogendeficientpreclinicalmodelofosteoporosisviamodulatingthehostosteoimmunesystem AT mishrapradyumnak cissusquadrangularishadjodinhibitsranklinducedosteoclastogenesisandaugmentsbonehealthinanestrogendeficientpreclinicalmodelofosteoporosisviamodulatingthehostosteoimmunesystem AT srivastavarupeshk cissusquadrangularishadjodinhibitsranklinducedosteoclastogenesisandaugmentsbonehealthinanestrogendeficientpreclinicalmodelofosteoporosisviamodulatingthehostosteoimmunesystem |